Table 3 The series of echocardiographic parameters among the icodextrin and glucose users

LAD (mm)

LVEDD (mm)

LVESD (mm)

LVEDV (mm³)

LVESV (mm³)

IVS (mm)

 Baseline (n = 21)

34.97 ± 7.51

50.80 ± 7.66

35.00 ± 6.35

124.71 ± 42.49

53.48 ± 21.83

12.65 ± 2.29

 After 12 months (n = 21)

36.90 ± 61.16

50.48 ± 7.93

34.90 ± 6.86

127.76 ± 40.22

50.24 ± 19.79

12.76 ± 2.10

 After 24 months (n = 20)

35.90 ± 10.99

50.85 ± 14.59

32.05 ± 10.46

121.35 ± 59.03

46.20 ± 31.98

11.45 ± 4.48

 P - value

0.001

0.195

0.063

0.003

0.004

0.004

 Baseline (n = 22)

32.25 ± 5.88

46.88 ± 6.36

30.49 ± 6.14

103.95 ± 34.34

39.00 ± 22.22

11.53 ± 1.79

 After 12 months (n = 21)

33.90 ± 5.08

47.24 ± 7.50

31.52 ± 6.61

106.43 ± 40.43

42.52 ± 23.15

11.33 ± 1.91

 After 24 months (n = 18)

34.83 ± 5.45

49.22 ± 8.43

31.67 ± 7.47

118.39 ± 47.99

43.67 ± 27.06

11.33 ± 1.78

 P - value

0.005

0.001

0.001

<  0.001

0.001

0.005

MPI

LVEF (%)

DT (ms)

Peak EDV (cm/s)

Septal EMV (ms)

E/e′

 Baseline (n = 21)

0.37 ± 0.19

57.81 ± 10.03

169.81 ± 73.50

71.89 ± 34.66

5.43 ± 3.00

11.70 ± 6.36

 After 12 months (n = 21)

0.43 ± 0.20

60.43 ± 7.29

214.24 ± 72.01

73.89 ± 27.94

6.05 ± 2.42

12.83 ± 6.60

 After 24 months (n = 20)

0.32 ± 0.21

56.55 ± 21.88

193.35 ± 75.03

65.80 ± 33.68

5.51 ± 2.28

11.51 ± 9.60

 P - value

0.195

0.068

0.081

0.150

0.035

0.104

 Baseline (n = 22)

0.49 ± 0.57

63.40 ± 9.51

213.60 ± 85.21

70.67 ± 28.75

5.94 ± 1.58

12.38 ± 5.24

 After 12 months (n = 21)

0.35 ± 0.18

60.67 ± 8.50

199.62 ± 79.76

66.52 ± 23.69

5.97 ± 3.11

10.46 ± 5.05

 After 24 months (n = 18)

0.30 ± 0.19

64.50 ± 8.58

201.94 ± 62.55

68.25 ± 20.31

7.57 ± 3.42

9.08 ± 4.35

 P - value

0.174

0.015

0.051

0.036

0.013

0.052